Linda Jenkinson - 07 Oct 2025 Form 4 Insider Report for USBC, Inc. (USBC)

Role
Director
Signature
/s/ Linda Jenkinson
Issuer symbol
USBC
Transactions as of
07 Oct 2025
Transactions value $
$0
Form type
4
Filing time
09 Oct 2025, 16:15:34 UTC
Previous filing
15 Aug 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jenkinson Linda Director 300 E 2ND STREET, 15TH FLOOR, RENO /s/ Linda Jenkinson 09 Oct 2025 0002081130

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction USBC Option to Purchase Common Stock Disposed to Issuer $0 -4.76M -100% $0.00 0 07 Oct 2025 Common Stock 4.76M $2.45 Direct F1
transaction USBC Option to Purchase Common Stock Award $0 +4.76M $0.00 4.76M 07 Oct 2025 Common Stock 4.76M $1.10 Direct F2
transaction USBC Option to Purchase Common Stock Award $0 +5.24M +110.08% $0.00 10M 07 Oct 2025 Common Stock 5.24M $1.10 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported involved the repricing of outstanding stock options to purchase 4,760,000 shares of common stock of USBC, Inc. (the "Company") pursuant to the Amended and Restated USBC, Inc. 2021 Equity Incentive Plan (the "Amended and Restated 2021 Plan"), initially granted on August 6, 2025 (the "Grant Date"). The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.
F2 On October 7, 2025, in accordance with the terms of the Amended and Restated 2021 Plan, the Board of Directors of the Company approved a repricing of outstanding stock options granted on August 6, 2025. The exercise price of each repriced option was reduced from $2.45 to $1.10 per share.
F3 On October 7, 2025, the Reporting Person was granted an option to purchase 5,240,000 shares of the Company's common stock pursuant to the Amended and Restated 2021 Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.